Immune to Cancer: The CRI Blog
-
Beyond Magic Bullets: Helen Coley Nauts and the Battle for Immunotherapy
How one woman who lacked a college degree took on the cancer establishment and changed the course…
-
‘Emperor of All Maladies’, Quotes That Make You Think
Three quotes from night one of #CancerFilm that stopped Emily Helck in her tracks.
-
A Run to Reach New Heights
Earlier this month, Team CRI runners ran the 2015 United Airlines Half Marathon in NYC.
-
Whose Cancer Is It, Anyway?
When navigating cancer with someone you love, does the experience belong to just one of you?
-
Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma
Data from a phase III trial indicate that Keytruda stands ready to become standard-of-care for advanced melanoma.
-
Longboarding in the Fight Against Cancer with James McGary
Professional longboarder James is going the distance: he's longboarding from Seattle to New York City to raise…
-
CRI Scientists Honored With Five AACR Awards
Carl June, Elizabeth Jaffee, James Allison, David Baltimore, and Owen Witte pick up prestigious cancer awards.
-
What Cancer Patients Need to Know About the Opdivo Approval
Now that Opdivo (nivolumab) has been FDA approved for two cancer types, many patients are wondering: what’s…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.